Myocarditis: Difference between revisions
| Line 11: | Line 11: | ||
==Clinical Features== | ==Clinical Features== | ||
*Typically young/few risk factors for CAD | *Typically young/few risk factors for CAD | ||
**Age at onset typically between 20-50 years | |||
*[[Chest pain]] | *[[Chest pain]] | ||
*No sensitive symptom or sign but can have flu like syndrome: fever, fatigue, myalgia, nausea and vomiting; tachycardia (out of proportion to fever), tachypnea, new onset CHF | *No sensitive symptom or sign but can have flu like syndrome: fever, fatigue, myalgia, nausea and vomiting; tachycardia (out of proportion to fever), tachypnea, new onset CHF | ||
Revision as of 01:44, 22 October 2018
Background
- Inflammatory cardiomyopathy (dilated cardiomyopathy) caused by necrosis of myocytes from infectious agents, their toxins, and cytotoxic effects of activated host immunity
- Majority caused by enterovirus (Cocksackie B) and adenovirus. Also influenza A/B, Hep B, B Hemolytic Streptococcus, Mycoplasma, Mumps, CMV and Toxoplasma (cardiac transplant), Chagas (leading cause worldwide) Trichinosis, Diphtheria, Lyme
- Drugs: Doxorubicin, Cocaine
Phases
- Acute: Viral cytotoxicity and focal necrosis
- Subacute: Host's humoral/immune response leading to further cell injury
- Chronic: Diffuse myocardial fibrosis and cardiac dysfunction
Clinical Features
- Typically young/few risk factors for CAD
- Age at onset typically between 20-50 years
- Chest pain
- No sensitive symptom or sign but can have flu like syndrome: fever, fatigue, myalgia, nausea and vomiting; tachycardia (out of proportion to fever), tachypnea, new onset CHF
- In Peds: grunting, retractions, ronchi. Infants may have fulminant syndrome: Fever, cyanosis, respiratory distress, tachycardia, cardiac failure, ventricular dysrhythmias
- May have pericardial friction rub
- Consider this diagnosis in the septic-appearing patient who gets WORSE after receiving IV fluids.
Differential Diagnosis
- Acute MI
- Pericarditis
- CHF
Evaluation
- ECG: Sinus tachycardia, low voltages, prolonged QTc, AV block, Acute MI pattern (Usually >1 vessel distribution)
- TropI: Elevated
- Echo: Decreased LVEF, global hypokinesis, regional wall motion abnormalities
- Contrast MR
- Nuclear Study: Widespread uptake indicating myocyte necrosis
- Viral titers
- Endocardial biopsy: Gold standard
Management
- Acute Phase: Antiviral agents may be effective with replicating virus: Pleconaril/Ribavirin
- Subacute: Studies have not shown efficacy of immunosupressants. Peds: High dose IVIG
- Chronic: Treat CHF symptoms, Ventricular Assist Devices (VAD), cardiac transplant
Disposition
- If CHF: Admit to monitored bed; ICU for hemodynamic instability
- Fulminant myocarditis has best prognosis
- Mortality: 20% 1 yr/ 50% 5 yr
- Children with 70% survival rate at 5 yrs
Complications
- Ventricular dysrhythmias
- LV anneurysm
- CHF
